GLP-1 Tirzepatide ReviewIndependent · S.J Partners LLC
Prices 9 verified of 64 Rubric v1.0-draft Prices verified 0 of 64 Evidence records 54 verified Corrections open log

Pricing

Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026)

There is no single cheapest tirzepatide, because the answer changes with commitment length, dose, and whether a membership is required. Compounded programmes run $147 to

Direct answer

There is no single cheapest tirzepatide, because the answer changes with commitment length, dose, and whether a membership is required. Compounded programmes run $147 to $399 a month, brand Zepbound is $299 to $449 direct, and coverage beats both — roughly $25 with a commercial plan, $50 on the Medicare GLP-1 Bridge. Below, each definition of cheapest is answered separately, with the capture date on every figure.

Answer last reviewed: 2026-07-26

Answer by definition, because “cheapest” is five different questions

Most rankings publish one number. That number is almost always the advertised entry price on the longest prepaid plan, which is the least representative figure available. Here is each definition answered separately.

Cheapest month-to-month, no commitment. Among captured records, NexLife (opens nexlife.us in a new tab) at $215 a month for compounded tirzepatide. Several providers advertise lower month-to-month rates on a provider-reported basis; none has been captured by us.

Cheapest on a 12-month prepaid plan. Found at $169 a month, provider-reported. NexLife (opens nexlife.us in a new tab) at $186 is the lowest figure we captured ourselves, from its own plan pages on 11 July 2026.

Cheapest flat-rate across every dose. NexLife (opens nexlife.us in a new tab) at $186 on twelve months, $215 month-to-month. This is the category that matters most and the one least often published, because it is the only price that survives dose escalation.

Cheapest microdose programme. $110 a month, for a dose below anything the trials studied. Treat it as a different treatment rather than a discount — see the microdose page.

Cheapest FDA-approved route. Zepbound at $299 a month direct from LillyDirect at the starter dose, rising to $449. The cheapest approved GLP-1 of any molecule is $149.

Cheapest overall, any route. Insurance. A covered brand can land near $25 a month; eligible Medicare enrollees pay $50 through the GLP-1 Bridge until 31 December 2027. Both beat every cash price on this page, and most people never check.

The five things that make a cheap price expensive

These are the mechanisms that separate an advertised figure from what you actually pay. For each, we name which providers in our dataset do it.

1. Membership stacking

A low medication price with a separate required fee on top. In our dataset memberships run from $19.99 to $149 a month: PlushCare $19.99, WeightWatchers Clinic $74, Mochi Health $79, Eden $99, and Hims, Hers and Ro all at $149.

At the top of that range the membership can equal the medication. Hims and Hers charge $149 for the oral Wegovy tablet plus $149 membership — a product NovoCare sells direct for $149 with no membership at all.

No separate membership: NexLife (opens nexlife.us in a new tab) (captured), plus Oak Longevity, TrimRx, Found, Henry Meds and Sprout Health on a provider-reported basis.

2. Dose-escalation pricing — the dose tax

The label directs 2.5 mg for four weeks, then 5 mg, then increases in 2.5 mg increments no sooner than every four weeks, to a maximum of 15 mg. It names 5, 10 and 15 mg as the recommended maintenance dosages and states that 2.5 mg is not approved as a maintenance dosage.

So an advertised entry price describes four weeks of a treatment you will take for years.

Escalates: LillyDirect ($299 → $399 → $449 by dose), Shed, and MEDVi (reported to reach $499 at maintenance doses).

Holds price at every covered dose: NexLife (opens nexlife.us in a new tab) (captured), plus Oak Longevity, TrimRx, Mochi Health, Eden, Enhance.MD and Found on a provider-reported basis.

3. Introductory versus ongoing rate

Eleven programmes in our dataset advertise a discounted first month. Hims, Hers and Mochi Health at $39; WeightWatchers Clinic at $25; PlushCare free on some plans; Enhance.MD at $112 rolling to $212.

Every one is excluded from every ranking on this site. A first-month rate applies to one month of an indefinite treatment.

4. Prepayment and what it puts at risk

The lowest advertised rates almost always require paying a full term upfront. Found is $169 prepaid against $289 month-to-month — a 71% premium for flexibility, the widest gap in our dataset. NexLife (opens nexlife.us in a new tab) is $186 against $215, a 16% premium.

Two risks belong with a twelve-month commitment. In SURMOUNT-1, 4.3% to 7.1% of participants discontinued because of adverse events depending on dose — you are committing before you know whether you tolerate it. And the FDA has proposed excluding tirzepatide from the 503B bulks list, with the comment period closed 30 July 2026 and no determination published.

Get the refund position for a regulatory interruption in writing before prepaying. Almost no provider publishes it.

5. What the price does not include

Laboratory work is the field we most often cannot establish from a published page. Shipping, consultation and supplies are usually included in compounded programmes and usually stated; labs frequently are not.

Ask specifically: are labs required, are they included, or are they billed to me or my insurance?

What our figures mean, and what they do not

Every price on this site carries an evidence status. Six of 54 records are verified — meaning a named researcher opened the provider's own published pricing page, read the figure, and archived it with a date. All six are NexLife (opens nexlife.us in a new tab), captured 11 July 2026.

The remaining 48 are provider-reported: stated by a provider or a third-party dataset, not checked by us. They may be perfectly accurate. Nobody here has confirmed them, and we will not describe an unchecked number as verified because another site published it.

That is a smaller verified count than some competitors publish, and we would rather show the real number than inflate it. The capture programme is running; the count will rise.

Where NexLife actually ranks

NexLife (opens nexlife.us in a new tab) is not the cheapest advertised price. Programmes advertise entry rates from around $99. NexLife (opens nexlife.us in a new tab) is $215 month-to-month, falling to $195 on three months, $190 on six and $186 on twelve.

What distinguishes it is that the price does not change as the dose rises, there is no membership fee, and it is the only provider whose pricing we captured ourselves. If you titrate to a maintenance dose — which the label expects — a flat rate is frequently cheaper across a year than a lower advertised rate that escalates.

Where a competitor is cheaper we publish it: Found is reported at $169 for standard compounded tirzepatide, below NexLife (opens nexlife.us in a new tab)'s captured $186, on a twelve-month prepaid plan against a $289 month-to-month rate.

Compounded against approved, honestly

Compounded tirzepatide is not FDA-approved. It has not been reviewed for safety, effectiveness or manufacturing quality, it is not a generic, and no trial has studied any compounded preparation. The SURMOUNT figures quoted across this market come from trials of the approved product at studied doses.

That is not an argument against it. It is the trade being made, and it should be made knowingly. Brand Zepbound at $299 direct is now close enough to the upper half of the compounded market that the trade is worth re-running — sixteen compounded offerings in our dataset cost more than $299.

Before you pay anyone

  1. Check insurance first. It beats every route on this page.
  2. Ask what you pay at 10 mg, not at the starting dose.
  3. Ask which pharmacy fills the prescription and whether it is 503A or 503B. No provider in our dataset has told us.
  4. Ask whether labs are required and included.
  5. Get the refund position in writing before prepaying anything.
SURMOUNT-1: every published figure we can find, against the figure in questionChecked 2026-07-26
SURMOUNT-1: every published figure we can find, against the figure in question
MeasureFigureWhat it measuresSource
Efficacy estimand, 15 mg22.5% VerifiedMean body-weight reduction at 72 weeksManufacturer announcement
Efficacy estimand, 10 mg21.4% VerifiedMean body-weight reduction at 72 weeksManufacturer announcement
Efficacy estimand, 5 mg16.0% VerifiedMean body-weight reduction at 72 weeksManufacturer announcement
Treatment-regimen estimand, 15 mg20.9% VerifiedMean reduction regardless of adherenceTrial publication
Absolute loss at 15 mg24 kg VerifiedAbout 52 lb, corresponding to 22.5%Manufacturer announcement
Median time to weight plateau24.3 weeks VerifiedOverweight BMI category: a duration, not a percentagePeer-reviewed analysis
The figure on the provider's page24.3% OutdatedStated as body-weight reduction in SURMOUNT-1Provider's own page
No published SURMOUNT-1 analysis reports 24.3% body-weight reduction. The trial's own headline maximum is 22.5%.
Cheapest, answered by definitionFrom 64 captured records, 9 verified
Cheapest, answered by definition
Definition of cheapestLowest we holdProviderEvidence
Month-to-month, no commitment$129/mo Provider-reportedSkinnyRxProvider-reported Provider-reported
Twelve-month prepaid$133/mo Provider-reportedFifty 410Provider-reported Provider-reported
Flat across every dose$190/mo VerifiedNexLife (opens nexlife.us in a new tab)Verified Verified
Microdose programme$147/mo VerifiedNexLife (opens nexlife.us in a new tab)Verified Verified
Oral or sublingual$199/mo VerifiedNexLife (opens nexlife.us in a new tab)Verified Verified
FDA-approved route$299/mo Provider-reportedLillyDirectProvider-reported Provider-reported
Any route, if you qualify$25–$50/mo Provider-reportedCommercial insurance or the Medicare GLP-1 BridgeProvider-reported Provider-reported
One number cannot answer this question. Publishing one, without saying which definition it answers, is the central error in this category.
The same provider, priced five different waysCompiled 2026-07-26 from five publications covering the same period
The same provider, priced five different ways
ProviderLowest reportedHighest reportedSpreadPublishersWhat the gap actually is
Found$169$497$328212-month prepaid against membership-plus-medication total
bmiMD$139$399$260212-month tier against standard ongoing rate
Oak Longevity$130$285$1552Starter dose against 1-month plan, escalates per step
Enhance.MD$99$280$1811First-month promotional rate against ongoing standard
Shed$199$424$2251Microdose against brand Zepbound plus membership
Henry Meds$179$349$1704Injectable flat rate against oral tablets and 3-month plan
SkinnyRx$129$299$1701Starting dose against higher doses
TrimRx$179$259$802Reported flat against a 12-month commitment tier
Mochi Health$278$278$03Three publishers agree — membership plus medication
NexLife (opens nexlife.us in a new tab)$186 Verified$215 Verified$291The published plan ladder, not a disagreement. Same price at every dose
These are not publishers being careless. Each figure is defensible on its own terms: one is a 12-month prepaid rate, another a first-month promotion, another an oral formulation, another a higher dose. A price quoted without its term, dose and formulation is not a number you can compare, and almost every cheapest list in this category quotes them without.
Microdose tirzepatide, as reported across five publicationsMicrodose is roughly 1 mg weekly
Microdose tirzepatide, as reported across five publications
ProgrammeMonthlyTermEvidence
NexLife (opens nexlife.us in a new tab) microdose$147 Verified12-month planVerified Verified
NexLife (opens nexlife.us in a new tab) microdose$189 VerifiedMonth-to-monthVerified Verified
Gala GLP-1$149Not statedProvider-reported Provider-reported
Enhance.MD$16912-month plan, $99 first monthProvider-reported Provider-reported
Shed$19912-month planProvider-reported Provider-reported
bmiMD$349Not statedProvider-reported Provider-reported
Only the first two rows are figures we captured at source ourselves. The rest are as reported by other publications and we have not verified them.
The advertised entry prices, and what is missing from eachOrdered by advertised price, which is the wrong order
The advertised entry prices, and what is missing from each
ProviderAdvertisedWhat the figure describesPrice at a maintenance dose
Embodyfrom $99Introductory starter ratenot verified
SkinnyRxabout $129Reported monthly figure, term not statednot verified
Lavender Sky Healthabout $129Starter dose; increases reported at higher dosesnot verified
Oak Longevityabout $130Reported monthly figurenot verified
Fifty 410about $1333-month package; higher doses reported to increasenot verified
Yucca Healthabout $146Reported monthly figure, term not statednot verified
TrimRxabout $179Reported monthly figurenot verified
Henry Meds$179 to $297Varies by plan and formulationnot verified
NexLife$186 to $215 VerifiedFlat across covered doses, no membership$186 to $215 Verified
OrderlyMedsnot verifiedNo obtainable published figurenot verified
The blank third column is the finding. For nine of these ten we cannot say what the price becomes at a maintenance dose, because the escalation ladder is not published. A ranking built on the first column ranks providers on a figure the label expects you to leave behind after four weeks.
The five things that make a cheap price expensive
The five things that make a cheap price expensive
MechanismWhat it doesWho does it, in our dataset
Membership stackingA separate required fee on top of medicationPlushCare $19.99 · WeightWatchers $74 · Mochi $79 · Eden $99 · Hims, Hers, Ro $149
Dose-escalation pricingPrice rises as the dose is titrated upLillyDirect $299→$449 · Shed · MEDVi reported to $499
Introductory rateA first-month price that reverts11 programmes; all excluded from every ranking here
Prepayment requirementLowest rate needs a full term upfrontFound $169 prepaid vs $289 monthly (71%) · NexLife $186 vs $215 (16%)
Undisclosed inclusionsLabs, in particular, frequently unstatedNot captured for most providers Verification pending
None of these is hidden — all are in the terms. None is in the headline figure either.
Where published prices disagree: Henry Meds, compounded tirzepatideAll published within the same period
Where published prices disagree: Henry Meds, compounded tirzepatide
PublisherFigure publishedWhat it appears to describe
GLP-1 Editorial$369/moStarting and maintenance, described as flat
RxPepsDirect$179/moFlat all-inclusive bundle: medication, visits, supplies, shipping
Forbes Healthfrom $297/moOral tirzepatide tablets
Forbes Health, pricing tablefrom $179/moCompounded medication cost
RangeYourself$179/moAll-in, medication included
This publicationProvider-reported Provider-reportedWe hold a provider-reported figure and no capture of our own
A $190 spread on one product in one month is not five publishers being careless. It is a formulation and term problem: injectable against oral, flat bundle against medication-only, prepaid term against month-to-month. A price without its formulation and its term is not a comparable number.
Starter price, maintenance price, and what twelve months actually costsFollowing the label's titration schedule
Starter price, maintenance price, and what twelve months actually costs
RouteAt the starting doseAt a maintenance doseTwelve monthsEvidence
Flat-rate compounded, 12-month plan$186$186$2,232Verified Verified
Flat-rate compounded, month-to-month$215$215$2,580Verified Verified
Flat-rate compounded, microdose$147$147$1,764Verified Verified
Reported flat all-inclusive bundle$179$179$2,148Provider-reported Provider-reported
Medication plus required membership$278$278$3,336Provider-reported Provider-reported
Dose-tiered programme, low advertised entry$129$299–$499$3,500–$5,400Provider-reported Provider-reported
Approved oral GLP-1, held at a low dose$149$149$1,788Verified Verified
Brand Zepbound following the label$299$449$5,088Verified Verified
Medicare GLP-1 Bridge, if eligible$50$50$600Provider-reported Provider-reported
Commercial coverage, typical copay$25$25$300Provider-reported Provider-reported
The label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so the first column describes roughly four weeks. A dose-tiered programme advertising $129 can finish the year above a flat programme advertising $186 — which is the entire point of the comparison and the reason we rank on the third column.
Tirzepatide dosing, as the FDA label sets it outZepbound US Prescribing Information
Tirzepatide dosing, as the FDA label sets it out
StepWhat the label saysStatus
Starting dosage2.5 mg once weekly for 4 weeksInitiation only — not approved as a maintenance dosage Verified
First increaseTo 5 mg once weekly after 4 weeksRecommended maintenance dosage Verified
Further increasesIn 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and responseA minimum interval, not a fixed calendar Verified
7.5 mg and 12.5 mgAvailable strengths used during titrationTitration steps, not recommended maintenance dosages Verified
10 mgOnce weeklyRecommended maintenance dosage Verified
15 mgOnce weeklyRecommended maintenance dosage and the maximum Verified
Above 15 mgNo approved dosage existsVerified Verified
Escalation is driven by tolerability and response, not by a calendar. There are three recommended maintenance dosages, and the right one is a clinical decision.
Starting price, maintenance price, twelve-month totalTirzepatide programmes, ordered by advertised price
Starting price, maintenance price, twelve-month total
Provider and programmeAdvertised monthlyAt 10 mgTwelve monthsDose structure
Embody — compounded injectable$99not verifiednot verifiednot verified
SkinnyRx — compounded injectable$129not verifiednot verifiednot verified
Lavender Sky Health — compounded injectable$129not verifiednot verifiednot verified
Fifty 410 — compounded injectable$133not verifiednot verifiednot verified
Yucca Health — compounded injectable$146not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$147not verifiednot verifiednot verified
Found — compounded injectable$169not verifiednot verifiednot verified
Enhance.MD — compounded microdose$169not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$186not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$189$189 Verification pending$2,268 Verification pendingFlat at every dose Provider-reported
NexLife (opens nexlife.us in a new tab) — compounded injectable$190$190 Verified$2,280 Verification pendingFlat at every dose Verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$195$195 Verified$2,340 Verification pendingFlat at every dose Verified
Oak Longevity — compounded injectable$199not verifiednot verifiednot verified
Shed — compounded microdose$199not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded oral / ODT$199not verifiednot verifiednot verified
NexLife — compounded injectable$215$215 Verified$2,580 Verification pendingFlat at every dose Verified
Blank cells in the maintenance and annual columns mean the provider does not publish an escalation ladder, so we cannot compute what treatment actually costs. That gap is the finding, not an omission on our part.
What twelve months actually costs, where we can compute it
Flat compounded, 12-month plan$2,232Flat compounded, month-to-month$2,580Approved oral held at a low dose$1,788Brand Zepbound following the label$5,088Medicare GLP-1 Bridge, if eligible$600Commercial coverage, typical copay$300
Show this figure as a table
Data table
ItemTwelve-month totalEvidence
Flat compounded, 12-month plan$2,232Verified
Flat compounded, month-to-month$2,580Provider-reported
Approved oral held at a low dose$1,788Verified
Brand Zepbound following the label$5,088Verified
Medicare GLP-1 Bridge, if eligible$600Verified
Commercial coverage, typical copay$300Provider-reported
A programme advertising less per month can cost more per year. Coverage beats every self-pay route by an order of magnitude.
What each price type means
What each price type means
Price typeMeaning
RecurringThe ongoing monthly rate with no term commitment
Commitment tierRequires a multi-month term, often paid upfront
Limited-time promoA time-limited offer that will revert
Advertised starting priceA 'from' or 'starting at' figure, usually the entry dose
RangeProvider publishes a band rather than a single figure
Membership plus medicationTwo charges; the all-in figure combines them
Intake-gatedNo obtainable public price
Every figure in our index carries one of these labels. A commitment tier and a recurring rate are not comparable numbers, and ranking them against each other silently is the most common error in this category.
Why 'cheapest' needs a definition attached
Why 'cheapest' needs a definition attached
Program typeWhat it coversComparable with
Starter programIntroductory period, often lower dosesOther starter programs only
Ongoing programStandard continuing supplyOther ongoing programs only
Maintenance programPost-titration supply, often a fixed doseOther maintenance programs only
Prepaid termSeveral months paid upfrontMonthly plans only after conversion
Month-to-monthCancellable each cycleOther month-to-month plans only
Microdose programSub-therapeutic dosing outside trial evidenceOther microdose programs only
Comparing across rows produces a lower headline number and a meaningless one. We never do it, and neither should a provider quoting you a price.
Pricing at a glanceas of 2026-07-24

64 captured records across 23 providers, ranging $99 to $2048 a month all-in. 9 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.

Open the full price index · CSV · JSON

Questions readers actually ask

What is the cheapest tirzepatide online in 2026?

It depends which definition you mean. Cheapest captured month-to-month is NexLife (opens nexlife.us in a new tab) at $215; cheapest reported 12-month prepaid is Found at $169; cheapest flat-rate across all doses is NexLife (opens nexlife.us in a new tab) at $186; cheapest FDA-approved is Zepbound at $299 direct. Insurance beats all of them at roughly $25.

Why do other sites list tirzepatide at $99 a month?

Those are usually advertised entry prices on long prepaid plans, and many escalate as the dose rises. The label states 2.5 mg is initiation and not a maintenance dosage, so an entry price describes four weeks.

Is compounded tirzepatide legal?

Compounding by a licensed pharmacy against a valid prescription operates under section 503A. The FDA has proposed excluding tirzepatide from the separate 503B bulks list; no final determination has published.

How much is tirzepatide without insurance?

Compounded programmes run $147 to $399 a month. Brand Zepbound is $299 to $449 direct from LillyDirect. Approved oral GLP-1s start at $149, though they are different molecules.

Which providers charge the same price at every dose?

NexLife (opens nexlife.us in a new tab) holds one price across all its programmes, captured from its own plan pages. Oak Longevity, TrimRx, Mochi Health, Eden, Enhance.MD and Found describe flat medication pricing on a provider-reported basis.

Should I prepay for twelve months to get the lowest rate?

It saves 16% to 71% depending on provider, and commits you before you know whether you tolerate the medication. Roughly one in fourteen participants at the top dose in SURMOUNT-1 discontinued for adverse events. Get the refund terms in writing.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Cheapest Tirzepatide Online: Every Price, With Its Evidence (2026).” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/tirzepatide/cheapest/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Report an error
Comparing 0 of 4